Drug Shortage Report for DILTIAZEM HYDROCHLORIDE INJECTION

Last updated on 2025-10-25 History
Report ID 255266
Drug Identification Number 02514095
Brand name DILTIAZEM HYDROCHLORIDE INJECTION
Common or Proper name DILTIAZEM HYDROCHLORIDE
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 5 mL & 10 x 10 mL vial / fiole
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-07-14
Actual start date 2025-07-14
Estimated end date 2025-11-30
Actual end date 2025-10-24
Shortage status Resolved
Updated date 2025-10-25
Company comments Product will remain on allocation.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v31 2025-10-25 English Compare
v30 2025-10-24 French Compare
v29 2025-10-24 English Compare
v28 2025-10-21 French Compare
v27 2025-10-21 English Compare
v26 2025-10-01 French Compare
v25 2025-10-01 English Compare
v24 2025-09-24 French Compare
v23 2025-09-24 English Compare
v22 2025-09-24 English Compare
v21 2025-08-11 French Compare
v20 2025-08-11 English Compare
v19 2025-07-16 French Compare
v18 2025-07-16 English Compare
v17 2025-07-15 English Compare
v16 2025-07-07 French Compare
v15 2025-07-07 English Compare
v14 2025-07-01 French Compare
v13 2025-07-01 English Compare
v12 2025-07-01 English Compare

Showing 1 to 20 of 31